Bristol-Myers Squibb Co. Live Share Price Today, Share Analysis and Chart

Name: Bristol-Myers Squibb Co.: Is Infosys Ltd. worth buying?
Item: Bristol-Myers Squibb Co.
Rating: 2.568430625
Author: Trendlyne DVM scores

Strong Performer, Under Radar

about

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol deriv...

46.86 -1.66 (-3.42%)

26.01% Fall from 52W High

13.7M

XNYS Volume

XNYS 11 Jul, 2025 5:30 PM (EDT)

High Financial Strength

55.6 / 100

Affordable Valuation

55.8 / 100

Technically Neutral

38.5 / 100

Strong Performer, Under Radar These stocks are with good quality scores and with strong financials. They are affordably priced stocks and can give good returns View Similar Embed DVM

1Yr Price target upside is 22%

21 analysts

Bristol-Myers Squibb Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Bristol-Myers Squibb Co. Live Share Price Today, Share Analysis and Chart

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol deriv...

26.01% Fall from 52W High

SWOT Analysis

Bristol-Myers Squibb Live Price Chart